Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Treatment of acute coronary syndromes by thrombin inhibition

March 16, 1998

Boehringer Ingelheim discloses new antiplatelet agents

March 13, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

First Rx for HIT type II approved in U.S.

March 10, 1998

U.S. patent covers use of MH-1 to deliver thrombolytics

March 5, 1998

3-D reveals new trypsin-like serine protease inhibitors

March 4, 1998

Acetaminophen increases risk of hemorrhage in combination with warfarin

March 4, 1998

Anticoagulants under development at Astra

March 3, 1998

Saruplase found equivalent to streptokinase in COMPASS trial

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...